Stanford University: Breast Neoplasms trials

The registry lists 48 Breast Neoplasms studies with Stanford University as lead sponsor. 4 are open to participants now and 12 have results posted.

Early Phase 1 2Phase 1 3Phase 2 11Phase 3 3No phase 30(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
• Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast CancerRecruitingNCT04768426Phase 2
• Magnetic Resonance Imaging of Breast CancerRecruitingNCT01035112Not applicable
• Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood SamplesRecruitingNCT01034033
• Decellularized, Whole Donor Nipple-Areola Complex Reconstruction GraftsTerminatedNCT04534010Not applicableResults posted
• Blossom Smart Expander Technology in Breast Reconstruction in Participants With Breast Cancer Undergoing MastectomyCompletedNCT03657069Not applicableResults posted
• Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerCompletedNCT03154190Not applicableResults posted
• Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation TherapyCompletedNCT02203565Phase 2Results posted
• Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast CancerTerminatedNCT01868503Phase 2Results posted
• Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast CancerCompletedNCT01771666Phase 2Results posted
• Development of Vitamin D as a Therapy for Breast Cancer - Phase 2CompletedNCT00656019Phase 2Results posted
• Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast CancerCompletedNCT00533780Not applicableResults posted
• Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast CancerTerminatedNCT00481845Phase 2Results posted
• Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk StatusCompletedNCT00383500Not applicableResults posted
• Phase 2 Study of Lovastatin as Breast Cancer ChemopreventionTerminatedNCT00285857Phase 2Results posted
• Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal WomenCompletedNCT00186121Phase 2Results posted
• Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and PoliciesCompletedNCT05916378
• Analysis of Patient Understanding of Radiation Therapy Among Patients With Breast CancerCompletedNCT05114525Not applicable
• Mental Health Disparities in Spanish Speaking Latina Breast Cancer PatientsCompletedNCT04834154Not applicable
• Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast CancerWithdrawnNCT04756765Phase 2
• Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial ResolutionWithdrawnNCT04016818Early Phase 1
• Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast CancerCompletedNCT03050463
• Radiofrequency-Guided Localization in Patients With Abnormal Breast Tissue Undergoing LumpectomyWithdrawnNCT02432118Not applicable
• Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer SurvivorsWithdrawnNCT02166983Not applicable
• Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility StudyWithdrawnNCT01780532Not applicable
• Phase I: At-Home Support for Rural Women Using Group Video CallingCompletedNCT01672684Phase 1
• Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast CancersWithdrawnNCT01360177Not applicable
• High Resolution 3D Diffusion-weighted Breast MRITerminatedNCT01315106
• Expanding Rural Access: Distance Delivery of Support Groups (Main Study)CompletedNCT01108016Phase 3
• Intellectual Impairment in Women With Breast CancerCompletedNCT00896324Not applicable
• Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CTTerminatedNCT00725946Early Phase 1
• Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRITerminatedNCT00695968
• MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving SurgeryWithdrawnNCT00695916Phase 3
• Molecular Analysis of Breast CancerCompletedNCT00569049
• Healing Touch During Chemotherapy Infusions for Women With Breast CancerCompletedNCT00533663Not applicable
• Sleep, Circadian Hormonal Dysregulation, and Breast Cancer SurvivalCompletedNCT00519168
• A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast CancerCompletedNCT00477139
• Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic BreastTerminatedNCT00473005Phase 1
• Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2CompletedNCT00383604
• Comprehensive Screening for Women at High Genetic Risk for Developing Breast CancerCompletedNCT00255060
• Stress, Diurnal Cortisol, and Breast Cancer SurvivalCompletedNCT00226967
• Psychosocial Treatment for Improving Chances of Survival in Women With Breast CancerCompletedNCT00226928Not applicable
• Group Therapy for Primary Breast CancerCompletedNCT00220792Phase 3
• CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous TransplantCompletedNCT00186680Phase 1/2
• Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer?CompletedNCT00186602
• Do Community Cancer Support Groups Reduce Physiological Stress in Women With Primary Breast Cancer?CompletedNCT00186524Phase 2
• Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging StudyCompletedNCT00185809
• Accelerated Partial Breast Irradiation Following Lumpectomy for Breast CancerActive, not recruitingNCT00185744Not applicable